Skip to main content

Trends in Inflammatory Bowel Disease Therapy 1999

The proceedings of a symposium organized by AXCAN PHARMA, held in Vancouver, BC, August 27–29, 1999

  • Conference proceedings
  • © 2000

Overview

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (25 papers)

  1. Genetics

  2. Clinical Challenges in Inflammatory Bowel Disease

  3. Current Therapy in Inflammatory Bowel Disease

  4. Bone Disease in Inflammatory Bowel Disease

Keywords

About this book

This Trends in Inflammatory Bowel Disease Therapy Symposium was held in Vancouver, British Columbia, Canada, 27~29 August 1999. This is the seventh international symposium, sponsored by Axcan Pharma Canada Inc., since the first symposium in 1986. The Canadian Association of Gastroenterology has co-sponsored these symposia since 1990. Each symposium has been published, and reflects and updates the extensive research and education, and the understanding of the mechanisms and treatment of inflammatory bowel disease. From the beginning, Canadian and international experts have been involved, maintaining a consistently high quality, both in their presentations, during discussions, and the subsequent publication of their work. There have been major advances since the symposium held two years ago, and these are presented in this book. In keeping with modern educational practice, objectives are provided, and all presentations were subject to written independent evalu­ ation. All participants are asked to declare any conflicts of interest. MOCOMP and educational credits are available.

Editors and Affiliations

  • Division of Gastroenterology, Department of Medicine, Dalhousie University, Halifax, Canada

    C. N. Williams

  • Faculty of Medicine, The Health Sciences Centre, Memorial University of Newfoundland, St John’s, Canada

    R. F. Bursey

  • Faculty of Medicine, The University of Calgary, Alberta, Canada

    D. G. Gall, L. R. Sutherland, J. L. Wallace

  • University of Montreal, Canada

    F. Martin

  • Mount Sinai Hospital, University of Toronto, Toronto, Canada

    R. S. McLeod

Bibliographic Information

  • Book Title: Trends in Inflammatory Bowel Disease Therapy 1999

  • Book Subtitle: The proceedings of a symposium organized by AXCAN PHARMA, held in Vancouver, BC, August 27–29, 1999

  • Editors: C. N. Williams, R. F. Bursey, D. G. Gall, F. Martin, R. S. McLeod, L. R. Sutherland, J. L. Wallace

  • DOI: https://doi.org/10.1007/978-94-011-4002-7

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media Dordrecht 2000

  • Hardcover ISBN: 978-0-7923-8762-6Published: 29 February 2000

  • Softcover ISBN: 978-94-010-5769-1Published: 05 November 2012

  • eBook ISBN: 978-94-011-4002-7Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XVI, 262

  • Topics: Gastroenterology

Publish with us